Oncomed Pharmaceuticals Inc (NASDAQ:OMED) highlighted data from several clinical studies that will be presented at the upcoming American Society for Clinical Oncology (ASCO) Annual Meeting being held May 30 — June 3, 2014 in Chicago, IL. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) net profit margin is -97.60% and weekly performance is -1.12%. On last trading day company shares ended up $22.96. Analysts mean target price for the company is $44.60. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) distance from 50-day simple moving average (SMA50) is -20.02%.
UV Flu Technologies, Inc. (OTCMKTS: UVFT) shares advanced 10.83% in last trading session and ended the day on $0.0399.
On 1 MAY 2014 SIGA Technologies, Inc. (NASDAQ:SIGA) a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, reported its financial results for the quarter ended March 31, 2014.Revenue for the three months ended March 31, 2014 was $549,000, compared to $1.3 million in the first quarter of 2013, and the operating loss for the quarter was $5.6 million, compared to $5.8 million for the comparable quarter last year. SIGA Technologies, Inc. (NASDAQ:SIGA) shares moved up 0.75%in last trading session and was closed at $2.68, while trading in range of $2.63 – $2.73. SIGA Technologies, Inc. (NASDAQ:SIGA) year to date (YTD) performance is -18.04%.
Stemline Therapeutics Inc (NASDAQ:STML) had its buy rating reaffirmed by analysts at Roth Capital. Stemline Therapeutics Inc (NASDAQ:STML) ended the last trading day at $12.89. Company weekly volatility is calculated as 9.47% and price to cash ratio as 3.86. Stemline Therapeutics Inc (NASDAQ:STML) showed a negative weekly performance of -9.48%.
On 14 MAY 2014 IMRIS Inc (NASDAQ:IMRS) provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment.IMRIS Inc (NASDAQ:IMRS) weekly performance is -6.09%. On last trading day company shares ended up $1.08. Analysts mean target price for the company is $2.80. IMRIS Inc (NASDAQ:IMRS) distance from 50-day simple moving average (SMA50) is -26.90%.